Doxazosin

Outcomes

1

Cardio-ankle vascular index

downin humans1downin reviews1

2 studies
  1. Doxazosin decreases cardio-ankle vascular index.

    “When doxazosin, an α1-adrenergic blocker, was administered, CAVI decreased”

    Review

    The Role of Monitoring Arterial Stiffness with Cardio-Ankle Vascular Index in the Control of Lifestyle-Related Diseases

    Pulse (Basel, Switzerland)20 Jun 2015

  2. Doxazosin decreases cardio-ankle vascular index in humans.

    “Furthermore, CAVI is decreased by an administration of α1 blocker, doxazosin for 2-4 hours”

    Review2-4 hours

    Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI)

    Current hypertension reviews1 Feb 2013

More on Cardio-ankle vascular index

Latest